Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Briacell Therapeutics Corp

(OTHER OTC: BCTXF)
Add to Portfolio
-0.0074 (-11.86%)
as of Sep 20, 2019

Last 0.0550
Change -0.0074 (-11.86%)
Open 0.0600
Prev. Close 0.0624
Today's Range
0.0475
0.0600
52wk Range
0.0391
0.1280
Volume 252,500
Avg Volume 69,250
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
BCTXF -11.86% -16.67% -45.00%
DJIA -0.59% -0.56% +1.04%
S&P 500 -0.49% -0.26% +2.09%

Key Statistics

Annual EPS -0.0500
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 12,300
Weighted Alpha -46.56
Standard Deviation -0.84
Profit Margin N/A
Beta 0.8700

Growth Rates

YTD +4.76%
1-Year -52.13%
3-Year -67.46%

Opinion

Sell Hold Buy

Recent Headlines

BriaCell Announces Private Placement of up to $600,000

GlobeNewswire via COMTEX - Fri Sep 20, 11:03AM EDT
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, is pleased to announce a non-brokered p(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015), MRK: 85.16 (+1.19)

IIROC Trading Resumption - BCT

CNW Group via COMTEX - Thu Sep 19, 11:29AM EDT
Trading resumes in:(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015)

BriaCell Announces Public Disclosure: Remarkable

GlobeNewswire via COMTEX - Thu Sep 19, 10:00AM EDT
Material information is being presented concurrent with this press release at 9:35am Eastern Time at the Next Gen Immuno-Oncology Congress. Publicly-traded securities of BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) will (full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015), MRK: 85.16 (+1.19)

IIROC Trading Halt - BCT

CNW Group via COMTEX - Thu Sep 19, 09:12AM EDT
The following issues have been halted by IIROC:(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015)

BriaCell to Present September 19th at 2nd Annual Next

GlobeNewswire via COMTEX - Mon Sep 16, 06:30AM EDT
BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announces that the Company will b(full story)
BCTXF: 0.0550 (-0.0074), BCT.VN: 0.065 (-0.015), MRK: 85.16 (+1.19), INCY: 81.21 (+3.09)